Sanofi has now created a NEW DTP Portal for allocations and prescription overrides. To access the portal please use:
You will need to create an account using your postcode, email and Phoenix account number that can be found in your Invoice. For Healthcare professionals who require further assistance related to quota overrides, please click here to email Sanofi directly.
We had never participated in a clinical trial before
- Personal and Professional Development Plan (PDP) including career planning
- Record of meetings with your educational and clinical supervisors
- Workplace-based assessments
- Sign-off documents
- Reflective reports and other evidence
A promising medication
The medication, called balovaptan, has already shown promising results in adults and has been given breakthrough designation by the Food and Drug Administration (FDA). When Nick decided to enroll in late 2017, the trial was enrolling kids ages 8 to 17. It has since opened to those ages 5 to 7.
“This is the first medication specifically targeting social communication skills in kids with autism,” says Kate Pawlowski, research manager for the study. “Treatments usually mediate symptoms, not the core issues of autism.”
